Interaction of purified tear lipocalin with lipid membranes

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 10, 2005, Pages 3649-3656

  Saaren Seppälä, Heikki ^a   Jauhiainen, Matti ^b   Tervo, Timo M T ^a   Redl, Bernhard ^c   Kinnunen, Paavo K J ^a   Holopainen, Juba M ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; IODINE; LIPOCALIN; LIPOSOME; LOW DENSITY LIPOPROTEIN; MEMBRANE LIPID; PHOSPHATIDYLCHOLINE; PYRENE; TRYPTOPHAN; CARRIER PROTEIN; CYSTEINE PROTEINASE INHIBITOR; EYE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOCALIN 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TEAR PROTEINS;

ARTICLE; CORNEA EPITHELIUM; HUMAN; LACRIMAL FLUID; LIPID MEMBRANE; LIPID TRANSPORT; LIPID VESICLE; LIPOPHILICITY; NORMAL HUMAN; PRESSURE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN PURIFICATION; RADIOMETRY; SURFACE PROPERTY; TECHNIQUE; FLUORESCENCE POLARIZATION; METABOLISM; RADIOASSAY; SPECTROFLUOROMETRY;

CARRIER PROTEINS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYSTEINE PROTEINASE INHIBITORS; EYE PROTEINS; FLUORESCENCE POLARIZATION; HUMANS; LIPOSOMES; MEMBRANE LIPIDS; PHOSPHATIDYLCHOLINES; RADIOLIGAND ASSAY; SPECTROMETRY, FLUORESCENCE;

EID: 32944480810     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0176     Document Type: Article

References (51)

1. Chen HB, Yamabayashi S, Ou Y, et al. Structure and composition of rat precorneal tear film: a study by an in vivo cryoftxation. Invest Ophthalmol Vis Sci. 1997;38:381-387.
2. King-Smith PE, Fink BA, Fogt N, Nichols KK, Hill RM, Wilson GS. The thickness of the human precorneal tear film: evidence from reflection spectra. Invest Ophthalmol Vis Sci. 2000;41:3348-3359.
3. Nichols JJ, King-Smith PE. Thickness of the pre- and post-contact lens tear film measured in vivo by interferometry. Invest Ophthalmol Vis Sci. 2003;44:68-77.
4. Wang J, Form D, Simpson TL, Jones L. Precorneal and pre- and postlens tear film thickness measured indirectly with optical coherence tomography. Invest Ophthalmol Vis Sci. 2003;44:2524-2528.
5. Nicolaides N, Kaitaranta JK, Rawdah TN, et al. Meibomian gland studies: comparison of steer and human lipids. Invest Ophthalmol Vis Sci. 1981;20:522-536.
6. McCulley JP, Shine WE. The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res. 2004;78:361-365.
7. Glasgow BJ, Marshall G, Gasymov OK, et al. Tear lipocalins: potential lipid scavengers for the corneal surface. Invest Ophthalmol Vis Sci. 1999;40:3100-3107.
8. Wolff, E. The muco-cutaneous junction of the lid margin and the distribution of the tear fluid. Trans Ophthalmol Soc UK 1946;66:291-308.
9. Brauninger GE, Shah DO, Kauffman HE. Direct physical demonstration of oily layer on tear film surface. Am J Ophthalmol. 1972;73:132-134.
10. Tran CH, Routledge C, Miller J, Miller F, Hodson SA. Examination of murine tear film. Invest Ophthalmol Vis Sci. 2003;44:3520-3525.
11. Greiner JV, Glonek T, Kord DR, Leahy CD. Meibomian gland phospholipids. Curr Eye Res. 1996;15:371-375.
12. McCulley JP, Shine WE. A compositional based model for tear film lipid layer. Trans Am Ophthalmol Soc. 1997;95:79-88.
13. McCulley JP, Shine WE. Meibomian secretions in chronic blepharitis. Adv Exp Med Biol. 1998;438:319-326.
14. Glasgow BJ, Abduragimov AR, Farahbakash Z, Faull KF, Hubbel WL. Tear lipocalins bind a broad array of lipid ligands. Curr Eye Res. 1995;14:363-372.
15. Flower DR. The lipocalin protein family: structure and function. Biochem J. 1996;318:1-14.
16. Breustedt DA, Korndörfer IP, Redl B, Skerra A. The 1.8 Å crystal structure of human tear lipocalin reveals an extended branched cavity with capacity for multiple ligands. J Biol Chem. 2005;280:484-493.
17. Gasymov OK, Abduragimov AR, Yusifov TN, Glasgow BJ. Site-directed tryptophan fluorescence reveals the solution structure of tear lipocalin: evidence for features that confer promiscuity in ligand binding. Biochemistry 2001;40:14754-14762.
18. Glasgow BJ. Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme. Graefes Arch Clin Exp Ophthalmol. 1995;233:513-522.
19. Fullard RJ. Identification of proteins in small tear volumes with and without size exclusion HPLC fractionation. Curr Eye Res. 1988;7:163-179.
20. Redl B. Human tear lipocalin. Biochim Biophys Acta. 2000;1482:241-248.
21. van't Hof W, Blankenvoorde MF, Veerman EC, Amerongen AV. The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor. J Biol Chem. 1997;272:1837-1841.
22. Redl B, Merschak P, Abt B, Wojnar P. Phage display reveals a novel interaction of human tear lipocalin and thioredoxin which is relevant for ligand binding. FEBS Lett. 1999;460:182-186.
23. Gasymov OK, Abduragimov AR, Yusifov TN, Glasgow BJ. Binding studies of tear lipocalin: the role of the conserved tryptophan in maintaining structure, stability and ligand affinity. Biochim Biophys Acta. 1999;1433:307-320.
24. Redl B, Holzfeind P, Lottspeich F. cDNA cloning and sequencing reveals human tear prealbumin to be a member of the lipophilicligand carrier protein superfamily. J Biol Chem. 1992;267:20282-20287.
25. 2. Biochemistry. 1993;32:5373-5380.
26. MacDonald RC, MacDonald RI, Menco BP, Takeshita K, Subbarao NK, Hu LR. Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim Biophys Acta. 1991;1061:297-303.
27. Wiedmer SK, Hautala J, Holopainen JM, Kinnunen PK, Riekkola ML. Study on liposomes by capillary electrophoresis. Electrophoresis. 2001;22:1305-1313.
28. Selvin PR. The renaissance of fluorescence resonance energy transfer. Nat Struct Biol. 2000;7:730-734.
29. l4C- phosphatidylcholine between liposomes and human plasma high density lipoprotein: partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim Biophys Acta. 1982;712:444-452.
30. Jauhiainen M, Metso J, Pahlman R, et al. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem. 1993;268:4032-4036.
31. Groener JE, Pelton R, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem. 1986;32:444-452.
32. Cheesman DF, Davies JT. Physicochemical and biological aspects of protein at interfaces. Adv Protein Chem. 1954;9:439-501.
33. Graham DE, Phillips MC. Proteins at liquid interfaces. J Colloid Interface Sci. 1979;70:403-414.
34. Ellison EH, Castellino FJ. Adsorption of vitamin K-dependent blood coagulation proteins to spread phospholipid monolayers as determined from combined measurements of the surface pressure and surface protein concentration. Biochemistry. 1998;37:7997-8003.
35. Dahim M, Brockman H. How colipase-fatty acid interactions mediate adsorption of pancreatic lipase to interface. Biochemistry. 1998;37:8369-8377.
36. Brockman H. Lipid monolayers: why use half a membrane to characterize protein-membrane interactions? Curr Opin Struct Biol. 1999;9:425-427.
37. Lakowicz JR. Principles of Fluorescence Spectroscopy. London, UK: Plenum Press; 1999:111-153.
38. Jauhiainen M, Setälä N, Ehnholm C, et al. Phospholipid transfer protein is present in human tear fluid. Biochemistry. 2005;44:8111-8116.
39. Verger H, Rietsch J, Van Dam-Mieras MC, de Haas GH. Comparative studies of lipase and phospholipase A2 acting on substrate monolayers. J Biol Chem. 1976;251:3128-3133.
40. White SH, Wimley WC. Hydrophobic interactions of peptides with membrane interfaces. Biochim Biophys Acta. 1998;1376:339-352.
41. Burova TV, Rabesona H, Choiset Y, et al. Why has porcine VEG protein unusually high stability and suppressed binding ability? Biochim Biophys Acta. 2000;1478:267-279.
42. Gasymov OK, Abduragimov AR, Yusifov TN, Glasgow BJ. Interaction of tear lipocalin with lysozyme and lactoferrin. Biochem Biophys Res Commun. 1999;265:322-325.
43. Nishida HI, Nishida T. Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholine- cholesterol vesicles to high density lipoproteine. J Biol Chem. 1997;272:6959-6964.
44. Huuskonen J, Wohlfahrt G, Jauhiainen M, et al. Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis. J Lipid Res. 1999;40:1123-1130.
45. Gasymov OK, Abduragimov AR, Yusifov TN, Glasgow BJ. Structural changes in human tear lipocalins associated with lipid binding. Biochim Biophys Acta. 1998;1386:145-156.
46. Oganesyan V, Oganesyan N, Terzyan S, et al. The crystal structure of the endothelial protein C receptor and a bound phospholipid. J Biol Chem. 2002;277:24851-24854.
47. II phase forming lipids. Chem Phys Lipids. 1992;63:251-258.
48. Abduragimov AR, Gasymov OK, Yusifov TN, Glasgow BJ. Functional cavity dimensions of tear lipocalin. Curr Eye Res. 2000;21:824-832.
49. Nagyova B, Tiffany JM. Components responsible for the surface tension of human tears. Curr Eye Res. 1999;19:4-11.
50. Verheij HM, Slotboom AJ, de Haas GH. Structure and function of phospholipase A2. Rev Physiol Biochem Pharmacol. 1981;91:91-203.
51. 2 catalysis. Proc Natl Acad Sci USA. 1977;74:1950-1954.